Bayer settles U.S. Roundup, dicamba and PCB litigation for more than $10 billion

In an expensive clean-up of Monsanto litigation messes, Bayer AG said Wednesday that it will pay out more than $10 billion to settle tens of thousands of U.S. claims brought against Monsanto over its Roundup herbicide, as well as $400 million to resolve lawsuits over Monsanto’s dicamba herbicide and $650 million for PCB pollution claims. … Continue reading “Bayer settles U.S. Roundup, dicamba and PCB litigation for more than $10 billion”

Roundup cancer attorney pleads guilty to extortion attempt

A Virginia lawyer who helped represent the first Roundup cancer plaintiff to take Monsanto to trial pleaded guilty on Friday to trying to extort $200 million from a chemical compound supplier to Monsanto. Timothy Litzenburg, 38, admitted to a scheme in which he and another lawyer threatened to inflict substantial “financial and reputational harm” on … Continue reading “Roundup cancer attorney pleads guilty to extortion attempt”

Roundup cancer plaintiffs eagerly await settlement news

Thousands of cancer patients and their families around the United States were notified this week that a comprehensive settlement of their claims against the former Monsanto Co. should be announced before the end of the month. Though specific settlement amounts for specific plaintiffs are still to be determined, groups of plaintiffs have been told to … Continue reading “Roundup cancer plaintiffs eagerly await settlement news”

Appeals court hears arguments over Monsanto’s first Roundup trial loss

A California jury decision blaming a Monsanto herbicide for a school groundskeeper’s cancer was deeply flawed and incompatible with the law, a Monsanto attorney told a panel of appellate judges on Tuesday. The company’s glyphosate-based herbicides – popularly known as Roundup – have the full backing of the Environmental Protection Agency (EPA) and “regulators around … Continue reading “Appeals court hears arguments over Monsanto’s first Roundup trial loss”

Dicamba: Farmers fear another season of crop damage; court ruling awaited

With the turn of the calendar to June, farmers in the U.S. Midwest are wrapping up the planting of new soybean crops and tending to growing fields of young corn plants and vegetable plots. But many are also bracing to be hit by an invisible enemy that has wreaked havoc in farm country the last … Continue reading “Dicamba: Farmers fear another season of crop damage; court ruling awaited”

Stuart Smyth’s agrichemical industry ties and funding

Stuart Smyth, PhD, promotes and defends genetically engineered foods and pesticides as an associate professor in the Department of Agricultural and Resource Economics at the University of Saskatchewan. Since 2014, he has held the Industry Funded Research Chair in Agri-Food Innovation. Industry funding Funders (described as “investing partners”) of Smyth’s research chair position include Bayer CropScience … Continue reading “Stuart Smyth’s agrichemical industry ties and funding”

Fresh talk of a settlement between Bayer and Roundup cancer patients

There was renewed talk of a potential settlement this week between Bayer AG and tens of thousands of cancer patients as a key court hearing looms next week. According to a report in Bloomberg, lawyers for Bayer have reached verbal agreements with U.S. lawyers representing at least 50,000 plaintiffs who are suing Monsanto over claims … Continue reading “Fresh talk of a settlement between Bayer and Roundup cancer patients”

Dicamba Fact Sheet

Dicamba (3,6-dichloro-2-methoxybenzoic acid) is a broad-spectrum herbicide first registered in 1967. The herbicide is used on agricultural crops, fallow land, pastures, turfgrass and rangeland. Dicamba is also registered for non-agricultural uses in residential areas and other sites, such as golf courses. At these types of sites, it is primarily used to control broadleaf weeds such as dandelions, chickweed, … Continue reading “Dicamba Fact Sheet”

Questions for the Bayer Shareholder Meeting: by Carey Gillam

Questions for the Bayer Shareholder Meeting: by Carey Gillam Earlier this year, our colleague Carey Gillam was offered a speaking slot by a Bayer shareholders’ group at the company’s annual meeting in Bonn, Germany. Due to Covid-19, the in-person meeting has been canceled and the Bayer shareholders convened in a virtual meeting on April 28 at … Continue reading “Questions for the Bayer Shareholder Meeting: by Carey Gillam”

Bayer shareholder meeting draws protests, pleas from cancer patients

The Bayer AG annual shareholders’ meeting got underway Tuesday in Germany, drawing the attention of not only investors and analysts but also activists, lawyers and cancer patients who want to see Bayer make amends for alleged misdeeds by Monsanto, which Bayer bought two years ago. The meeting was to be an in-person event in Bonn, … Continue reading “Bayer shareholder meeting draws protests, pleas from cancer patients”

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved